Evidently, a Palo Alto, CA-based provider of an AI platform for healthcare workflows, has raised $15 million in Series A funding.
Investors
The round was led by DN Capital, with participation from FRAMEWORK, Clear Ventures, and Fellows Fund.
DN Capital is a global early-stage and growth capital investor focused on Seed, Series A, and select Series B investments in fintech, SaaS, digital media, e-commerce, marketplaces, mobile applications, and software companies. The firm was founded in 2000 and has operations in London, Berlin, and Silicon Valley.
As part of the investment, Gulsah Wilke, Partner at DN Capital, will join Evidently’s board of directors.
Evidently Use of Funds
The funds will be used to meet product demand and expand into population health and clinical research analytics.
About Evidently
Evidently is a cognitive AI platform that enables healthcare providers to access and utilize clinical data effectively. It acts as an AI resident, intelligently synthesizing information from disparate sources, including external health records and faxes, and delivers concise, actionable summaries alongside real-time decision support. The company empowers clinicians to deliver care while reducing burnout and driving institutional success. It was founded in 2020 and is based in Palo Alto, California.
Funding Details
Company: Evidently, Inc.
Raised: $15.0M
Round: Series A
Funding Date: December 2024
Lead Investor: DN Capital
Additional Investors: FRAMEWORK, Clear Ventures, Fellows Fund
Company Website: https://evidently.com/
Software Category: Healthcare
Source: https://www.finsmes.com/2024/12/evidently-closes-15m-series-a-funding.html